Insights & Discussion
Discover Related Insights
A lower dose of iron amino acid chelate was not as effective as the standard iron salts dose in increasing ferritin levels in a predominantly iron-replete female Cambodian population.
2023 The Journal of Nutrition Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noni Fischer JAJ, Pei LX, Elango R, Hou K, Goldfarb DM, Karakochuk CD
Clinical Study Iron Deficiency
The research used a double-blind, randomized placebo-controlled noninferiority trial conducted in Cambodia. Participating nonpregnant women, aged 18-45, were randomly assigned either 60mg ferrous sulfate, 18mg ferrous bisglycinate or a placebo for 12 weeks. Baseline and 12-week post blood and fecal samples were collected from the participants and used to measure ferritin and fecal calprotectin levels as well as to detect the presence of enteropathogens.
The study found that mean ferritin concentration was higher at 12 weeks in those receiving ferrous sulfate dose compared to those receiving a lower dose of ferrous bisglycinate and a placebo. No significant changes were observed across the groups in terms of fecal calprotectin concentrations or detection of enteropathogens. Therefore, it was concluded that the 18mg dose of ferrous bisglycinate was not as effective as the 60mg ferrous sulfate dose in increasing ferritin concentrations.
Iron supplementation with ferrous bisglycinate in Cambodian women of reproductive age may increase the abundance of certain bacteria, including potential enteric pathogens.
2023 Microbiology Spectrum The Effect of Oral Iron Supplementation on Gut Microbial Composition: a Secondary Analysis of a Double-Blind, Randomized Controlled Trial among Cambodian Women of Reproductive Age Finlayson-Trick E, Nearing J, Fischer JAJ, Ma Y, Wang S, Krouen H, et al.
Randomised Controlled Trial Iron Deficiency
The study involved a secondary analysis of a double-blinded, randomized controlled trial examining the impact of two different oral iron supplements, ferrous sulfate and ferrous bisglycinate, or placebo on the gut microbiomes in Cambodian women of reproductive age (WRA) over a period of 12 weeks. Stool samples were provided by the participants at the beginning and end of the study for gut microbial analysis. This analysis consisted of 16S rRNA gene sequencing and targeted real-time PCR.
In terms of results, it was found that iron supplementation did not significantly change the overall diversity of the gut microbiome in these predominantly iron-replete Cambodian WRA. However, ferrous bisglycinate did lead to an increase in the relative abundance of and showed a trend of an increase for another strain of bacteria, Escherichia. Furthermore, the presence of a virulence gene associated with enteropathogenic Escherichia coli was detected in a greater quantity in the stool samples of those who took ferrous sulfate. This suggests that while the overall biodiversity of the gut microbiome remained stable, certain potential pathogen-associated bacterial populations may have increased due to the iron supplementation.
Ferrous bisglycinate, an innovative amino acid iron chelate, showed increased absorption and fewer gastrointestinal side effects when used as an iron supplement in pregnant women.
2023 Nutrition Reviews The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials Fischer JAJ, Cherian AM, Bone JN, Karakochuk CD
Meta-Analysis Iron Deficiency
Methodology: The team carried out a systematic review and meta-analysis of randomized controlled trials (RCTs) through a comprehensive survey of electronic databases and grey literature up to July 17, 2020, to ascertain the impacts of ferrous bisglycinate versus other iron supplements on hemoglobin and ferritin levels and gastrointestinal (GI) adverse events. Exercises were undertaken to calculate averages from these trials which involved pregnant women and children and these average estimates were communicated as standardized mean differences. The rate of occurrence for GI adverse events was determined using Poisson generalized linear mixed-effects models. Studies involving other subjects (men and non-pregnant women) were evaluated on an individual basis.
Discussion of Results: The results reveal fermentable bisglycinate demonstrating an advantage over other iron supplements. Among the pregnant women involved in the trials, those using this supplement had higher hemoglobin levels after 4-20 weeks of administration. Additionally, these women reported reduced GI adverse events. Although the observed increase in ferritin levels was not marked as significant, it depicted an upward trend. However, no notable differences were detected in either hemoglobin or ferritin concentrations in children using ferrous bisglycinate.
Dark chocolate exerts prebiotic effects and may improve negative emotional states via the gut-brain axis.
2022 The Journal of Nutritional Biochemistry Consumption of 85% cocoa dark chocolate improves mood in association with gut microbial changes in healthy adults: a randomized controlled trial Shin JH, Kim CS, Cha L, Kim S, Lee S, Chae S, et al.
Randomised Controlled Trial Dark Chocolate Gut Microbiota Mental Health
To assess the association between the mood-altering effects of dark chocolate and the gut microbiota, we performed fecal 16S rRNA sequencing analysis for the DC85 and CON groups. Gut microbial diversity was significantly higher in DC85 than CON (P<.05). Blautia obeum levels were significantly elevated and Faecalibacterium prausnitzii levels were reduced in DC85 compared to CON (P<.05). Furthermore, we found that the observed changes in negative affect scores were negatively correlated with diversity and relative abundance of Blautia obeum (P<.05).
Goji berries, notably their polysaccharides, exhibit protective effects against inflammatory bowel disease through the preservation of healthy gut microbiota.
2022 Critical Reviews in Food Science and Nutrition Prebiotic effects of goji berry in protection against inflammatory bowel disease Sun Q, Du M, Kang Y, Zhu MJ
Review Article Goji Berry Gut Microbiota Inflammatory Bowel Disease
The review encompassed an in-depth analysis of current literature specially focusing on the role of goji berry and its important functional constituents in countering Inflammatory Bowel Disease (IBD). The core attentiveness of the research is directed towards understanding the interplay between goji berries, particularly their polysaccharides, and gut microbiota. The goji berries’ protective effects were evaluated, focusing on how they curb disruption in gut microbiota, a common facet in IBD.
The review concluded that goji berries, especially their polysaccharides, demonstrated appreciable benefits in averting gut microbiota disturbances seen with IBD, thus protecting against this condition. These natural substances, present in goji berries, function as prebiotics, which maintain a balanced gut microbial ecosystem. The research further revealed that proper functioning of gut microbiota and their metabolites was a crucial element in mediating these beneficial effects against IBD, thus cementing the role of dietary interventions in managing diseases linked with gut health.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.